Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer
D. Oluwalana, K. L. Adeleye, R. I. Krutilina, H. Chen, H. Playa, S. Deng, D. N. Parke, J. Abernathy, L. Middleton, A. Cullom, B. Thalluri, D. Ma, B. Meibohm, D. D. Miller, T. N. Seagroves, W. Li
This study evaluates the biological activity of 60c, a next-generation colchicine-binding site inhibitor, showing improved potency and anti-metastatic effects in triple-negative breast cancer models.
bioRxiv · May 22, 2024Cancer Biology